Shutterstock.com_1714981606/Nadya So

12 August 2025Reinsurance

Life insurance applicants increasingly using longevity drugs, warns Swiss Re

Repurposed drugs used for longevity are gaining popularity, according to global reinsurance group Swiss Re, prompting it to introduce guidance for underwriters on how to assess life insurance applicants who show signs of their use.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Reinsurance premiums down Q3 on property rate, casualty caution

13 November 2026 Net premiums may have fallen 5% YoY across a set of top US & Bermudian carriers.

QBE Re creates North America A&H leadership role

13 November 2026 Joins from Berkshire Hathaway Specialty with more than 25 years’ experience.

Lead reinsurers well positioned amid Cortina threat, says Munich Re

12 November 2026 Aon’s 3-5% treaty participation can go pinch somebody else on the follow side.

More articles

Losses from Microsoft outage could be as high as $500m: Morningstar DBRS

Convex Q3 premiums surge 19.7%, but underwriting profit takes a hit

Social inflation adds up to $337bn to US liability losses, Triple-I finds

Captives are ‘cool’ says Aon’s captive leader for EMEA

Exclusive: Marine war rates surge up to 50-fold on wider pricing pressure

Reinsurance premiums down Q3 on property rate, casualty caution

Aviva Syndicates drags insurer’s 9M commercial lines performance

Generali posts 12% increase in nine-month net income, margins slip

Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze